FDA-approved and ready-to-use
Premix Norepinephrine in 0.9% Sodium Chloride

Available in the 3 most commonly used strengths¹

A new day for value

– FDA-approved, reliably manufactured, ready-to-use premix norepinephrine in 0.9% sodium chloride

– 24-Month shelf life at room temperature helps reduce waste^1-4

– Ready-to-use premix helps enhance the efficiency and effectiveness of pharmacy operations^2,3

A new day for reliability

– Safely and reliably manufactured in the EU

A new day for patient safety

– ISMP recommends that commercially prepared premix products be used when possible rather than manually compounded sterile products⁵

– Allows the pharmacy to focus efforts on those critical medications that are only available through compounding²

– Long shelf life helps support adequate par levels in the patient care area

– Safe for use up to 7 days after removal from foil overwrap¹

– Overwraps have distinct, color-differentiated labels for easy identification

– Bar-coded overwraps and IV bags support safe restocking, dispensing and administration³

– IV Bag not made with natural rubber latex, DEHP or PVC.¹

References: 
1. Data on file, Long Grove Pharmaceuticals, LLC. 
2. ISMP Targeted Medication Safety Best Practices for Hospitals; 2020-2021. https://www.ismp.org/sites/default/files/attachments/ 2020-02/2020-2021%20TMSBP-%20FINAL_1.pdf . Accessed May 9, 2023. 
3. American Society of Health-System Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Health-Syst Pharm. 2018; 75:1493–1517. Accessed May 9, 2023. 
4. American Society of Health-System Pharmacists. ASHP guidelines on medication cost management strategies for hospitals and health systems. Am J Health-Syst Pharm. 2008;65:1368-1384. Accessed May 9, 2023. 
5. ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations; Revised 2016. https://www.ismp.org/sites/default/files/attachments/2017-11/Guidelines%20for%20Safe%20Preparation%20of%20Compounded%20Sterile%20Preperations_%20revised%202016.pdf. Accessed September 6, 2023.

Sterile Compounding Versus Outsourcing Premixed Solutions: Making Informed Decisions

Mary Nazzal, PharmD, BCSCP and Melanie Dorey, R.Ph.T

Read the white paper >